Acrivon Therapeutics Inc. (ACRV)
NASDAQ · Healthcare
Acrivon Therapeutics Inc. Cash on Hand 2020–2025
Acrivon Therapeutics Inc. annual cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Acrivon Therapeutics Inc. cash on hand as of December 31, 2025: 41.5M, a 4.22% increase year-over-year.
- Acrivon Therapeutics Inc. cash on hand for 2025 were 41.5M, a 4.22% increase from 2024.
- Acrivon Therapeutics Inc. cash on hand for 2024 were 39.8M, a 10.56% increase from 2023.
- Acrivon Therapeutics Inc. cash on hand for 2023 were 36.0M, a 22.01% increase from 2022.
- Acrivon Therapeutics Inc. cash on hand for 2022 were 29.5M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Acrivon Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $41 |
| 2024 | $40 |
| 2023 | $36 |
| 2022 | $30 |
| 2021 | $100 |
| 2020 | $2 |
Acrivon Therapeutics Inc. Cash on Hand — FAQ
Acrivon Therapeutics Inc. (ACRV) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ACRV's cash on hand history?
The chart and table above show Acrivon Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.